These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 33980167)

  • 1. Teicoplanin versus β-lactam for febrile patients with Staphylococcus-like bacteremia: focus on methicillin-susceptible Staphylococcus aureus bacteremia.
    Tsai CY; Lee CH; Chen IL
    BMC Infect Dis; 2021 May; 21(1):437. PubMed ID: 33980167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of outcomes in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia who are treated with β-lactam vs vancomycin empiric therapy: a retrospective cohort study.
    Wong D; Wong T; Romney M; Leung V
    BMC Infect Dis; 2016 May; 16():224. PubMed ID: 27215201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effectiveness of β-lactam versus vancomycin empiric therapy in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia.
    Wong D; Wong T; Romney M; Leung V
    Ann Clin Microbiol Antimicrob; 2016 Apr; 15():27. PubMed ID: 27112143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia.
    Kim SH; Kim KH; Kim HB; Kim NJ; Kim EC; Oh MD; Choe KW
    Antimicrob Agents Chemother; 2008 Jan; 52(1):192-7. PubMed ID: 17984229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of β-Lactam and Daptomycin Combination Therapy on Clinical Outcomes in Methicillin-susceptible Staphylococcus aureus Bacteremia: A Propensity Score-matched Analysis.
    Grillo S; Cuervo G; Carratalà J; Grau I; Pallarès N; Tebé C; Guillem Tió L; Murillo O; Ardanuy C; Domínguez MA; Shaw E; Gudiol C; Pujol M
    Clin Infect Dis; 2019 Oct; 69(9):1480-1488. PubMed ID: 30615122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Administration of Adjuvant β-Lactam Therapy in Combination with Vancomycin among Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: A Retrospective, Multicenter Analysis.
    Casapao AM; Jacobs DM; Bowers DR; Beyda ND; Dilworth TJ;
    Pharmacotherapy; 2017 Nov; 37(11):1347-1356. PubMed ID: 28949410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The empirical combination of vancomycin and a β-lactam for Staphylococcal bacteremia.
    McConeghy KW; Bleasdale SC; Rodvold KA
    Clin Infect Dis; 2013 Dec; 57(12):1760-5. PubMed ID: 23985343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of Vancomycin plus a β-Lactam versus Vancomycin Only for Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia.
    Truong J; Veillette JJ; Forland SC
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia.
    Schweizer ML; Furuno JP; Harris AD; Johnson JK; Shardell MD; McGregor JC; Thom KA; Cosgrove SE; Sakoulas G; Perencevich EN
    BMC Infect Dis; 2011 Oct; 11():279. PubMed ID: 22011388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Outcomes of Daptomycin Versus Anti-Staphylococcal Beta-Lactams in Definitive Treatment of Methicillin-susceptible Staphylococcus aureus Bloodstream Infections.
    Agnello S; Wardlow LC; Reed E; Smith JM; Coe K; Day SR
    Int J Antimicrob Agents; 2021 Aug; 58(2):106363. PubMed ID: 34033912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Clinical Outcomes for Glycopeptides and Beta-Lactams in Methicillin-Susceptible
    La YJ; Kim HR; Oh DH; Ahn JY; Kim YC
    Yonsei Med J; 2022 Jul; 63(7):611-618. PubMed ID: 35748072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Empirical combination of a β-lactam to vancomycin may not improve outcomes of methicillin-susceptible Staphylococcus aureus bacteremia, compared to vancomycin monotherapy.
    Park GE; Ko JH; Cho SY; Ha YE; Lee NY; Kang CI; Chung DR; Song JH; Peck KR
    Eur J Clin Microbiol Infect Dis; 2017 Jul; 36(7):1091-1096. PubMed ID: 28078559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Effectiveness of Cefazolin Versus Nafcillin or Oxacillin for Treatment of Methicillin-Susceptible Staphylococcus aureus Infections Complicated by Bacteremia: A Nationwide Cohort Study.
    McDanel JS; Roghmann MC; Perencevich EN; Ohl ME; Goto M; Livorsi DJ; Jones M; Albertson JP; Nair R; O'Shea AMJ; Schweizer ML
    Clin Infect Dis; 2017 Jul; 65(1):100-106. PubMed ID: 28379314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-Lactam Therapy for Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Comparative Review of Cefazolin versus Antistaphylococcal Penicillins.
    Li J; Echevarria KL; Traugott KA
    Pharmacotherapy; 2017 Mar; 37(3):346-360. PubMed ID: 28035690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial.
    Tong SYC; Lye DC; Yahav D; Sud A; Robinson JO; Nelson J; Archuleta S; Roberts MA; Cass A; Paterson DL; Foo H; Paul M; Guy SD; Tramontana AR; Walls GB; McBride S; Bak N; Ghosh N; Rogers BA; Ralph AP; Davies J; Ferguson PE; Dotel R; McKew GL; Gray TJ; Holmes NE; Smith S; Warner MS; Kalimuddin S; Young BE; Runnegar N; Andresen DN; Anagnostou NA; Johnson SA; Chatfield MD; Cheng AC; Fowler VG; Howden BP; Meagher N; Price DJ; van Hal SJ; O'Sullivan MVN; Davis JS;
    JAMA; 2020 Feb; 323(6):527-537. PubMed ID: 32044943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of Reporting a Prior Penicillin Allergy on the Treatment of Methicillin-Sensitive Staphylococcus aureus Bacteremia.
    Blumenthal KG; Shenoy ES; Huang M; Kuhlen JL; Ware WA; Parker RA; Walensky RP
    PLoS One; 2016; 11(7):e0159406. PubMed ID: 27438379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy of teicoplanin in the treatment of bloodstream infection caused by methicillin-resistant coagulase-negative staphylococci.
    Yamada K; Ueda T; Nakajima K; Ichiki K; Tsuchida T; Otani N; Takahashi Y; Ikeuchi H; Uchino M; Koshiba M; Takesue Y
    J Infect Chemother; 2020 May; 26(5):459-464. PubMed ID: 31870587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant β-Lactam Therapy Combined with Vancomycin for Methicillin-Resistant
    Dilworth TJ; Casapao AM; Ibrahim OM; Jacobs DM; Bowers DR; Beyda ND; Mercier RC
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30617094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daptomycin versus placebo as an adjunct to beta-lactam therapy in the treatment of Staphylococcus aureus bacteremia: study protocol for a randomized controlled trial.
    Cheng MP; Lawandi A; Butler-Laporte G; Paquette K; Lee TC
    Trials; 2018 May; 19(1):297. PubMed ID: 29843781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High vancomycin MIC and complicated methicillin-susceptible Staphylococcus aureus bacteremia.
    Aguado JM; San-Juan R; Lalueza A; Sanz F; Rodríguez-Otero J; Gómez-Gonzalez C; Chaves F
    Emerg Infect Dis; 2011 Jun; 17(6):1099-102. PubMed ID: 21749780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.